ZAMBELLO, RENATO

ZAMBELLO, RENATO  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 20 di 367 (tempo di esecuzione: 0.048 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study 2025 Pizzi, MarcoFriziero, AlbertoBertozzi, IreneBinotto, GianniDei Tos, Angelo PaoloCeccato, JessicaCinetto, FrancescoPiazza, FrancescoVisentin, AndreaZambello, RenatoTrentin, LivioVianello, Fabrizio + JOURNAL OF CLINICAL MEDICINE - -
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group 2024 Sartori, RobertoPavan, LauraZambello, Renato + ANNALS OF HEMATOLOGY - -
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience 2024 Pavan, LauraZambello, Renato + CANCER MEDICINE - -
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy 2024 Zambello, Renato + EJHAEM - -
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 2024 Zambello, RenatoTarantini, Giuseppe + HAEMATOLOGICA - -
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials 2024 Zambello, RenatoTarantini, Giuseppe + HEMATOLOGICAL ONCOLOGY - -
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma 2024 Zambello, Renato + BLOOD - -
Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia 2024 Gasparini V. R.Teramo A.Calabretto G.Rampazzo E.Carraro S.Trimarco V.Trentin L.Facco M.Zambello R. + HAEMATOLOGICA - -
Proteasome Inhibitors Induce Apoptosis in Ex Vivo Cells of T-Cell Prolymphocytic Leukemia 2024 Gasparini, Vanessa RebeccaRampazzo, ElisaBuratin, AlessiaCalabretto, GiuliaOrsi, SilviaTonini, AlessiaTeramo, AntonellaTrentin, LivioFacco, MonicaBortoluzzi, StefaniaZambello, Renato + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
T-cell clones of uncertain significance. When is the rogue clone dangerous? 2024 Teramo, AntonellaCalabretto, GiuliaZambello, Renato + HAEMATOLOGICA - -
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders 2024 Calabretto, GiuliaTeramo, AntonellaGasparini, Vanessa RebeccaRampazzo, ElisaZambello, Renato + BLOOD CANCER JOURNAL - -
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a “rare in rare” scenario 2024 Scapinello, GretaDel Prete, DorellaVisentin, AndreaVianello, FabrizioZambello, RenatoCastellani, ChiaraFedrigo, MarnyRizzo, StefaniaAngelini, AnnalisaTrentin, LivioPiazza, Francesco + CANCER REPORTS - -
Imaging minimal residual disease evaluation in multiple myeloma using [18F]FDG PET/MRI 2023 Crimì, FilippoPavan, LauraCabrelle, GiulioCecchin, DiegoZambello, Renato + LEUKEMIA & LYMPHOMA - -
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial 2023 Zambello, Renato + ECLINICALMEDICINE - -
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis 2023 Zambello, Renato + HAEMATOLOGICA - -
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL 2023 Zambello, Renato + BLOOD ADVANCES - -
Not all LGL leukemias are created equal 2023 Calabretto, GiuliaGasparini, Vanessa RebeccaTeramo, AntonellaZambello, Renato + BLOOD REVIEWS - -
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel 2023 Zambello, Renato + EJHAEM - -
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies 2023 D’Amore, FabioPavan, LauraPiazza, FrancescoPravato, StefanoScapinello, GretaVianello, FabrizioZambello, RenatoPadoan, AndreaTrentin, LivioVisentin, Andrea + FRONTIERS IN ONCOLOGY - -
Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients 2023 Teramo A.Calabretto G.Gasparini V. R.Zambello R. + BLOOD - -